WuXi AppTec Co., Ltd. (SHA:603259)

China flag China · Delayed Price · Currency is CNY
68.41
+4.05 (6.29%)
Feb 21, 2025, 3:00 PM CST
32.65%
Market Cap 196.37B
Revenue (ttm) 38.50B
Net Income (ttm) 8.06B
Shares Out 2.89B
EPS (ttm) 2.75
PE Ratio 24.89
Forward PE 18.10
Dividend 1.01 (1.48%)
Ex-Dividend Date Jun 26, 2024
Volume 75,372,254
Average Volume 41,859,734
Open 64.50
Previous Close 64.36
Day's Range 64.50 - 69.25
52-Week Range 36.36 - 69.25
Beta 0.84
RSI 78.70
Earnings Date Mar 18, 2025

About WuXi AppTec

WuXi AppTec Co., Ltd., an investment holding company, provides research and manufacturing services to discover, develop, and manufacture spectrum for small molecule drugs and advanced therapies in the People’s Republic of China, the United States, Europe, and internationally. The company operates in six segments: WuXi Chemistry, WuXi Testing, WuXi Biology, WuXi ATU, WuXi DDSU, and Others. It offers contract research, development, and manufacturing organization services for new drug development from discovery to commercial covering various categ... [Read more]

Sector Healthcare
Founded 2000
Employees 41,116
Stock Exchange Shanghai Stock Exchange
Ticker Symbol 603259
Full Company Profile

Financial Performance

In 2023, WuXi AppTec's revenue was 40.34 billion, an increase of 2.51% compared to the previous year's 39.35 billion. Earnings were 9.61 billion, an increase of 9.00%.

Financial Statements

News

There is no news available yet.